Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. filed its Monthly Return for the period ended 31 May 2026, confirming that no movements occurred in either its Hong Kong-listed H shares or Shanghai STAR Market A shares. The report was lodged with Hong Kong Exchanges and Clearing Limited on 3 June 2026.

The company’s issued share structure remained unchanged: • H shares: 326.00 million outstanding, representing registered capital of RMB 32.60 million. • A shares: 710.57 million outstanding, representing registered capital of RMB 71.06 million.

Aggregate registered share capital stayed at RMB 103.66 million, reflecting a par value of RMB 0.10 per share across both classes.

Management confirmed that the H-share public float continues to meet the Hong Kong Exchange’s minimum requirement of 5 % of the class’s issued shares.

No share options, warrants, convertible instruments, treasury shares, repurchases, or other equity-related movements were recorded during the month.